[Plasma substance P assay and the clinical significance].
Tamai
H
H
Department of Psychosomatic Medicine, Faculty of Medicine, Kyushu University.
Matsubayashi
S
S
Yanaihara
N
N
D000681:Amylases / Q000378:metabolism; D000818:Animals; D002276:Carcinoid Tumor / Q000175:diagnosis; D013006:Growth Hormone / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000175:diagnosis; D006801:Humans; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D011388:Prolactin / Q000378:metabolism; D011863:Radioimmunoassay / Q000379:methods*; D013373:Substance P / Q000097:blood* / Q000378:metabolism / Q000502:physiology; D014018:Tissue Distribution
D007328:Insulin; D013373:Substance P; D011388:Prolactin; D013006:Growth Hormone; D000681:Amylases